Paul Lorigan

Has grant

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Translational research for CACTUS study 2018

Open Date: 2018-01-01

Close Date:

Grant: Close

Expand PIANO Study to EORTC Centres

Open Date: 2017-01-01

Close Date:

Grant: Close

CACTUS: Biomarker driven treatment decision making in advanced melanoma.

Open Date: 2016-01-01

Close Date:

Grant: Close

Planned switch to combination immunotherapy in primary refractory melanoma

Open Date: 2016-01-01

Close Date:

Grant: Close

CRUK/12/020: A Phase II Trial of PLX3397 in KIT Mutant Acral and Mucosal Melanoma

Open Date: 2015-09-01

Close Date: 2019-08-31

Articles (22)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Sara Valpione

Honorary Senior Lecturer

The University of Manchester

UNITED KINGDOM

View details

Rotem Leshem

The University of Manchester

UNITED KINGDOM

View details

Joseph J. Sacco

Clinical Senior Lecturer

University of Liverpool

UNITED KINGDOM

View details

Mario Falchi

King’s College London

UNITED KINGDOM

View details

Peter Sasieni

King’s College London

UNITED KINGDOM

View details

Sophie Papa

King’s College London

UNITED KINGDOM

View details

Leonie Taams

King’s College London

UNITED KINGDOM

View details

Claus Garbe

Professor of Dermatology

Eberhard Karls Universität Tübingen

GERMANY

View details

Rebecca Lee

The University of Manchester

UNITED KINGDOM

View details

Lesley Rhodes

The University of Manchester

UNITED KINGDOM

View details

Jürgen C Becker

GERMANY

View details

Alexander Christopher Jonathan van Akkooi

Associate Professor

Melanoma Institute Australia

AUSTRALIA

View details

Tracy Epton

The University of Manchester

UNITED KINGDOM

View details

Christos Evangelou

University of Alabama, Tuscaloosa

UNITED STATES

View details

Katherine Payne

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Lorigan

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (22)

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research.

Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Mining nucleic acid “omics” to boost liquid biopsy in cancer

Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study

Nilotinib in KIT-driven advanced melanoma

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma

Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023

Adjuvant therapy for stage II melanoma

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma

Immune checkpoint inhibitor-mediated hypophysitis

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models

On the potential beneficial effects of indoor tanning

Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

Diagnosis and treatment of Merkel cell carcinoma

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

European consensus-based interdisciplinary guideline for melanoma. Part 1

European consensus-based interdisciplinary guideline for melanoma. Part 2

Collaborators (15)

Sara Valpione

Rotem Leshem

Joseph J. Sacco

Mario Falchi

Peter Sasieni

Sophie Papa

Leonie Taams

Claus Garbe

Rebecca Lee

Lesley Rhodes

Jürgen C Becker

Alexander Christopher Jonathan van Akkooi

Tracy Epton

Christos Evangelou

Katherine Payne

Make your next move.